Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP-01.1 in healthy volunteers following influenza A challenge
NCT02071329Phase 2Completed
- Sponsor
- Immune Targeting Systems
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Antisense DNA, Vaccines & Immunotherapeutics, Small Interfering RNA (siRNA)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A (IAV) comparing Vaccine FP-01.1 with Placebo (2 arms). Primary endpoint: Safety. Started Jan 2014; status: completed.
02
Drugs
FP-01.1
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02071329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071329.